Biomediq is improving breast cancer screening with our patented image analysis technology. We need to expand the development team for our breast cancer risk assessment product and are looking for a senior developer...Are you interested?
See our latest results in
Alzheimer's and Breast Cancer Risk Analysis
The BreastIQ framework from Biomediq offers automatic, computer-based analysis of mammograms for analysis of future risk of breast cancer.Read more
The research project on Alzheimer's disease (AD) focuses on localized atrophy markers for AD from structural magnetic resonance imaging (MRI) images of the brain. Two approaches are considered: Static volumetric measurements for atrophy scoring in subcortical brain structures for diagnosis of AD. Longitudinal scoring in subcortical brain structures for AD treatment response monitoring.Read more